Christine Helman

Christine Helman serves as a key procurement professional within the W4PZ USA Medical Research Acquisition Act, operating under the Department of the Army’s W81XWH program office. She manages complex acquisitions focused on advancing military medical innovation, overseeing contracts that translate cutting-edge biomedical research into field-deployable diagnostic, therapeutic, and analytical systems. Her portfolio emphasizes high-technology life science solutions, including laboratory instrumentation, medical device manufacturing, and specialty chemical processes critical to warfighter health and readiness. Helman’s work bridges the gap between scientific discovery and operational capability, ensuring that procurement strategies align with the Department of Defense’s strategic imperatives for next-generation medical technologies. Her contractor relationships span advanced manufacturing and life sciences sectors, engaging with firms specializing in analytical laboratory instruments, surgical and medical device production, and basic organic chemical synthesis. While no single contractor dominates her portfolio, she consistently partners with both large-capability vendors and agile small businesses capable of rapid prototyping and technical customization. Her procurement approach prioritizes technical rigor, supply chain resilience, and innovation responsiveness, fostering long-term vendor collaborations grounded in performance-based contracting and milestone-driven deliverables. Helman’s contracting patterns reflect a strong preference for open competition, with 88.9% of awards issued without set-aside restrictions. Nevertheless, she actively supports small business participation, dedicating 11.1% of acquisitions to Total Small Business Set-Asides under FAR 19.5, demonstrating a deliberate commitment to fostering innovation from emerging vendors without compromising technical requirements. Her primary industry focus lies in NAICS 325120 and 325199 for specialty chemical feedstocks, 334516 for precision analytical instrumentation, and 339112 for sterile, deployable surgical and diagnostic devices. These categories underscore her technical expertise in biomedical engineering, clinical diagnostics, and chemical process manufacturing—domains essential to sustaining the warfighter’s medical edge in austere environments.